TocilizumabVaricella infection and recurrent upper respiratory tract infection: 2 case reports

被引：0

作者：

机构：

来源：

Reactions Weekly | 2017年 / 1649卷 / 1期

关键词：

D O I：

10.1007/s40278-017-29516-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：237 / 237

相关论文

共 50 条

[11] Alemtuzumab/rituximabNeutropenia, urinary tract infection and upper respiratory tract infection and off label use: 3 case reports
Reactions Weekly, 2022, 1913 (1) : 31 - 31
[12] Vitamin D - An Elixir for Recurrent Upper Respiratory Tract Infection
M A Maqbool
K. S. Gangadhara Somayaji
V G Nayana
Indian Journal of Otolaryngology and Head & Neck Surgery, 2023, 75 : 1370 - 1375
[13] TofacitinibDiarrhoea and respiratory tract infection: 3 case reports
Reactions Weekly, 2019, 1749 (1) : 377 - 377
[14] Upper respiratory tract infection
Del Mar, CB
Glasziou, P
AMERICAN FAMILY PHYSICIAN, 2002, 66 (11) : 2143 - 2144
[15] RituximabUrinary tract infection caused by Escherichia coli and fatal respiratory infection: 2 case reports
Reactions Weekly, 2020, 1832 (1) : 260 - 260
[16] RECURRENT UPPER RESPIRATORY INFECTION
HUTCHISO.JH
PRACTITIONER, 1971, 206 (1236) : 844 - &
[17] OmalizumabRecurrent upper respiratory tract infection: case report
Reactions Weekly, 2018, 1696 (1) : 290 - 290
[18] InfliximabInterstitial lung disease and recurrent upper respiratory tract infections: 2 case reports
Reactions Weekly, 2021, 1868 (1) : 221 - 221
[19] InfliximabPneumocystis jiroveci pneumonia and recurrent urinary tract infection: 2 case reports
Reactions Weekly, 2014, 1532 (1) : 119 - 119
[20] AdalimumabDevelopment of anti-adalimumab antibodies and upper respiratory tract infection: 3 case reports
Reactions Weekly, 2019, 1749 (1) : 16 - 16

← 1 2 3 4 5 →